Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : EROX Corp and pheremones -- Ignore unavailable to you. Want to Upgrade?

To: Tom Caruthers who wrote (532)	12/22/1998 5:16:00 PM
From: Terror	Read Replies (1) \| Respond to of 562

Tom After I took the plunge and bailed out of EROX I put all the extra money into TWX. Kicking great stock. Today hit 59 and I'm letting it ride. Feel I would rather have blue chip stocks that are working in favor than sit on dead money. Everyone in EROX knows only too well how that feels. Noticed it went down again today. Hate that. If you want a good stock for 1999 look into Time Warner. Cable, music, movies, AT&T deal, TCI connection, Roadrunner, internet, magazines.....and a great company with top management. Marcie

To: Tom Caruthers who wrote (532)	1/14/1999 9:12:00 AM
From: trofala	Read Replies (1) \| Respond to of 562

MK Global Ventures Adds to 20% Stake in Human Pheromone Sciences, Inc. Through $600,000 Series BB Convertible Preferred Stock Purchase Investment Follows Announcement of Strategic Supply Agreement With Multi Billion Dollar Cosmetics Marketer PALO ALTO, Calif., Jan. 14 /PRNewswire/ -- Michael Kaufman, General Partner of MK Global Ventures, today announced that MK Global Ventures and affiliates have added a $600,000 purchase of Human Pheromone Sciences, Inc., ''HPSI'' (Nasdaq: EROX - news) Series BB convertible preferred stock to their existing 20% stake in the Company. The investment consists of 6,000 shares of Series BB stock, at $100 per preferred share. Under terms of the purchase, holders of HPSI Series BB convertible preferred shares may convert their holdings to the Company's common shares, listed on Nasdaq under the ticker symbol EROX, at any time. The Series BB shares initially convert to common shares automatically at a 100-to-1 ratio, resulting in an effective conversion price of $1 per common share. MK Global Ventures remains Human Pheromone Sciences largest institutional shareholder. Michael Kaufman, Managing General Partner of MK Global Ventures, commented, ''We see our stake in Human Pheromone Sciences as an investment in fundamental technology that is only starting to be understood as scientific validation increases. Management's recent announcement of a corporate licensing agreement with a major, multi-national cosmetics company validates our existing and continued investments in this company. HPSI has the rare opportunity to harness a previously untapped source of consumer product innovations offering a unique and broad-based appeal.'' ''Our stake in HPSI, and this increase in our stake, is grounded in the immediate and long-term potential for the development of pheromone-based consumer products that affect human moods and emotions,'' continued Mr. Kaufman. ''The fragrance additive industry is a multi-billion market place made up primarily of commodity ingredients. HPSI is in the position to attack this market by providing consumer products companies with a proprietary additive that can add true product differentiation on the retail shelf. The goal is for HPSI's patented compounds to do for smell what Nutrasweet® has done for taste